Holdings of ANDERA PARTNERS
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 5 in 3 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Evommune Inc | 1,897,362 | 43.6M $ | |
| 2 | Mineralys Therapeutics Inc | 1,591,917 | 43.1M $ | |
| 3 | AGOMAB THERAPEUTICS SA | 1,538,702 | 16.1M $ | |
| 4 | Inventiva SACA | 1,818,181 | 10.1M $ | |
| 5 | Abivax SA | 78,125 | 8.7M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 71.3 %
- France 15.4 %
- Belgium 13.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 2 | 86.7M $ | 71.29 % |
| 2 | France | 2 | 18.8M $ | 15.44 % |
| 3 | Belgium | 1 | 16.1M $ | 13.27 % |
Cite this page
Titelia. "Holdings of ANDERA PARTNERS". https://titelia.com/en/funds/US13F1757283